4-(3-(((8-(tert-butyl)-3,3-dimethyl-3,11-dihydropyrano[3,2-a]carbazol-5-yl)methyl)amino)propoxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide

ID: ALA5287744

Chembl Id: CHEMBL5287744

Max Phase: Preclinical

Molecular Formula: C33H36N4O6S

Molecular Weight: 616.74

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)C=Cc2c(c(CNCCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc3c2[nH]c2ccc(C(C)(C)C)cc23)O1

Standard InChI:  InChI=1S/C33H36N4O6S/c1-32(2,3)22-12-13-27-25(19-22)26-18-21(29-24(28(26)35-27)14-15-33(4,5)42-29)20-34-16-9-17-41-30-31(37(38)43-36-30)44(39,40)23-10-7-6-8-11-23/h6-8,10-15,18-19,34-35H,9,16-17,20H2,1-5H3

Standard InChI Key:  MSWBZJPTKBWQPI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5287744

    ---

Associated Targets(Human)

MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 616.74Molecular Weight (Monoisotopic): 616.2356AlogP: 5.82#Rotatable Bonds: 9
Polar Surface Area: 133.39Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.38CX LogP: 4.99CX LogD: 3.97
Aromatic Rings: 5Heavy Atoms: 44QED Weighted: 0.16Np Likeness Score: 0.05

References

1. Zang Y, Huang L, Chen X, Li C, Ma J, Chen X, Zhang D, Lai F..  (2022)  Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.,  244  [PMID:36270090] [10.1016/j.ejmech.2022.114832]

Source